Upkara

Upkara Develops Biopreservation Technology to Eliminate the Cold Chain Requirement for Therapeutics, Vaccines, and ReagentsUpkara Inc. offers an anhydrous bioglass technology that does not require temperature control. Its rapid stabilization process preserves products in a proprietary medium, protecting them from extreme temperatures. The technology enables biologics, vaccines, nucleic acids, blood products, and more to be stored at ambient and varying temperatures without compromising their functionality, allowing healthcare providers to eliminate reliance on cold chain storage and distribution.